3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
12
Neoplasms
8
Prostatic Neoplasms
4
Neoplasm Metastasis
4
Lung Neoplasms
3
Gastrointestinal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Brain Neoplasms
3
Sarcoma
2
Pain
2
Multiple Myeloma
2
Melanoma
2
Hematologic Neoplasms
2
Fatigue
2
Esophageal Neoplasms
2
Carcinoma, Hepatocellular
2
Weight Loss
1
Uterine Cervical Neoplasms
1
To Observe Whether the Fucoidan Can Improve the Quality of Life of the Such Patients Receiving the Neoadjuvant CCRT
1
Thymus Neoplasms
1
Thrombocytopenia
1
Symptom Management
1
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Splenomegaly
1
Speech
1
Sexual Dysfunction, Physiological
1
Sex Cord-Gonadal Stromal Tumors
1
Sarcoma, Synovial
1
Rectal Neoplasms
1
Interventions
Surveys and Questionnaires
7
Standard of Care
5
Sirolimus
5
Bevacizumab
5
temsirolimus
4
Interviews as Topic
4
Paclitaxel
3
olaparib
2
Vorinostat
2
Olanzapine
2
Magnetic Resonance Spectroscopy
2
Gemcitabine
2
Everolimus
2
Erlotinib Hydrochloride
2
Dasatinib
2
Cetuximab
2
zaleplon
1
vistusertib
1
tilsotolimod
1
pazopanib
1
olanzapine-fluoxetine combination
1
nimotuzumab
1
liposomal doxorubicin
1
capivasertib
1
apatinib
1
Videotape Recording
1
Vemurafenib
1
Valproic Acid
1
Trastuzumab
1
Topotecan
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Advanced Cancer
×
Quality of Life
×
Clear all
NCT01444157
2014-07-18
FamCope
Bispebjerg Hospital
Phase 3
Completed
700 enrolled